Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM - Nordestgaard, Børge G.; Langlois, Michel R.; Langsted, Anne; Chapman, M. John; Aakre, Kristin M.; Baum, Hannsjörg; Borén, Jan; Bruckert, Eric; Catapano, Alberico; Cobbaert, Christa; Collinson, Paul; Descamps, Olivier S.; et al. (Atherosclerosis, 2020)
Keywords: Apolipoprotein B; Atherosclerosis - etiology; Atherosclerosis - prevention & control; Atherosclerotic cardiovascular disease; Humans; Hyperlipidemias - complications; Hyperlipidemias - drug therapy; Hypolipidemic Agents - therapeutic use; LDL cholesterol; Life Sciences; Lipoprotein(a); Lipoproteins - physiology; non-HDL cholesterol; Remnant cholesterol; Apolipoprotein B; Lipoprotein(a); Atherosclerotic cardiovascular disease; LDL cholesterol; Remnant cholesterol; non-HDL cholesterol